CNN reported on Friday that the US Food and Drug Administration authorised a new test that diagnoses both influenza and for COVID-19, CNN reported on Friday.
The test, designed by the US Centers for Disease Control and Prevention (CDC), is the first dual test to get emergency use authorisation from the FDA.
FDA Commissioner Stephen Hahn was quoted as saying in a statement:
"With the authorisation of these tests, the FDA is helping address concerns in anticipation of this upcoming flu season during the COVID-19 pandemic, which might be especially worrying for some Americans."
"With just one swab or sample, combination tests can be used to get answers to Americans faster. This efficiency can go a long way to providing timely information for those sick with an unknown respiratory ailment," Hahn added.
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
GSK reports positive Phase III data for low-carbon version of Ventolin inhaler
Merck reports long-term survival benefits of Keytruda in non-small cell lung cancer
Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults
AstraZeneca wins US FDA approval for Tezspire in chronic rhinosinusitis with nasal polyps
Sichuan Kelun-Biotech presents positive Phase 3 trial results for sac-TMT
SOPHiA DDM Digital Twins launched to simulate patient outcomes and support oncology decisions
Novocure announces presentation of new TTFields research at EANO and ESMO 2025 meetings
Mabwell to present latest 7MW3711 clinical results at 2025 ESMO Congress
Actinium Pharmaceuticals to reveal ATNM-400 data in NSCLC at AACR-NCI-EORTC International Conference
Tempus selected by ARPA-H to provide CRO and testing services for ADAPT cancer programme
Polarean expands Ascend Imaging partnership to boost US market reach